<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
The following study was designed to investigate if mutations within the p53 gene are associated with radiation responsiveness or response to different cytotoxic drugs. Nine human lung cancer cell lines were examined (four SCLC and five NSCLC cell lines). cDNA-based sequencing of the entire p53 gene was performed. All cell lines were characterised with respect to drug-sensitivity towards eight cytotoxic drugs using the FMCA method and data from the clonogenic assay were studied to obtain information concerning radioresponsiveness. All the cell lines expressed mutations; six were missense mutations and three were deletions. A statistically significant increase in radiosensitivity was found for mutations in exon 7 (p = 0.019), compared with the other mutations localised within different exons of p53. Further statistical analyses using Fisher's two-tailed exact test confirmed that mutations in exon 7 were significantly associated with radiosensitivity, p = 0.047. No correlation concerning mutations in separate exons and response towards different chemotherapeutic agents could be found. Our results indicate that p53 mutations in exon 7 might be associated with increased radiation sensitivity in these human lung cancer cell lines, but our data should be interpreted with caution since several other explanations might exist regarding what determines the response towards radiation.
Lung Neoplasms, Paclitaxel, DNA Mutational Analysis, Cytarabine, Mutation, Missense, DNA, Neoplasm, Docetaxel, Exons, Genes, p53, Radiation Tolerance, Drug Resistance, Multiple, Neoplasm Proteins, Doxorubicin, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cladribine, Humans, Cisplatin, Melphalan
Lung Neoplasms, Paclitaxel, DNA Mutational Analysis, Cytarabine, Mutation, Missense, DNA, Neoplasm, Docetaxel, Exons, Genes, p53, Radiation Tolerance, Drug Resistance, Multiple, Neoplasm Proteins, Doxorubicin, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cladribine, Humans, Cisplatin, Melphalan
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 19 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |